Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;18(1):125-126.
doi: 10.4103/1673-5374.343895.

The intricate debate on neurodegeneration and neuroinflammation in Parkinson's disease: which came first?

Affiliations

The intricate debate on neurodegeneration and neuroinflammation in Parkinson's disease: which came first?

Antonella Cardinale et al. Neural Regen Res. 2023 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
The inflammatory mechanism induced by alpha-synuclein accumulation. Formation of toxic α-synuclein in Parkinson’s disease (PD), specifically at the presynaptic terminal, leads to changes of proteins involved in synaptic transmission (i.e., SNARE complex alteration and increased glutamate release), determining synaptic dysfunction and contributing to degeneration of dopaminergic neurons. Moreover, α-synuclein aggregation could be considered as a causal link between neurodegeneration and neuroinflammation in PD, inducing astrocyte and microglia reaction, consequent release of cytokines and activation of adaptive immune system. SNARE: Soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor.

References

    1. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197–211. - PubMed
    1. Bras IC, Xylaki M, Outeiro TF. Mechanisms of alpha-synuclein toxicity:An update and outlook. Prog Brain Res. 2020;252:91–129. - PubMed
    1. Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M. Direct and indirect pathways of basal ganglia:a critical reappraisal. Nat Neurosci. 2014;17:1022–1030. - PubMed
    1. Calo L, Hidari E, Wegrzynowicz M, Dalley JW, Schneider BL, Podgajna M, Anichtchik O, Carlson E, Klenerman D, Spillantini MG. CSPalpha reduces aggregates and rescues striatal dopamine release in alpha-synuclein transgenic mice. Brain. 2021;144:1661–1669. - PMC - PubMed
    1. Cardinale A, Calabrese V, de Iure A, Picconi B. Alpha-synuclein as a prominent actor in the inflammatory synaptopathy of Parkinson's disease. Int J Mol Sci. 2021;22:6517. - PMC - PubMed

LinkOut - more resources